Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Washington University
mi
from
St Louis, MO
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Washington University
mi
from
St Louis, MO
Click here to add this to my saved trials
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Center for Movement Disorders and Neurorestoration
mi
from
Gainesville, FL
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Center for Movement Disorders and Neurorestoration
mi
from
Gainesville, FL
Click here to add this to my saved trials
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Dauer Hall, University of Florida
mi
from
Gainesville, FL
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Dauer Hall, University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
University of Miami
mi
from
Miami, FL
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
University of South Florida
mi
from
Tampa, FL
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Emory University
mi
from
Atlanta, GA
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
URGE-PD: A Multi-site, Double-blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Birmingham, AL
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Los Angeles, CA
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Tampa, FL
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Atlanta, GA
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Chicago, IL
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Kansas City, KA
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Boston, MA
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
New York, NY
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Philadelphia, PA
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Houston, TX
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/23/2015
mi
from
Marburg,
STEPS Trial - Spheramine Safety and Efficacy Study
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/23/2015
mi
from
Marburg,
Click here to add this to my saved trials
Genetic Analysis of Parkinson's Disease
Genetic Analysis of Parkinson's Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Genetic Analysis of Parkinson's Disease
Genetic Analysis of Parkinson's Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Gene Analysis of Parkinson's Disease
Gene Analysis in Parkinson's Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Gene Analysis of Parkinson's Disease
Gene Analysis in Parkinson's Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance
Dopaminergic Modulation of Cerebral Connectivity During Sequential Finger Movements
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance
Dopaminergic Modulation of Cerebral Connectivity During Sequential Finger Movements
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cell Studies of Parkinson's Disease
Bioenergetic Function in Parkinson's Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Cell Studies of Parkinson's Disease
Bioenergetic Function in Parkinson's Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Sequence Effect in Parkinson's Disease
The Characteristics of Sequence Effect in de Novo and Advanced Parkinson's Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Sequence Effect in Parkinson's Disease
The Characteristics of Sequence Effect in de Novo and Advanced Parkinson's Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
University of Southern California
mi
from
Los Angeles, CA
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
The Parkinson's Institute
mi
from
Sunnyvale, CA
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
The Parkinson's Institute
mi
from
Sunnyvale, CA
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Pacific Health Research & Education Institute
mi
from
Honolulu, HI
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Pacific Health Research & Education Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Struthers Parkinson`S Center
mi
from
Golden Valley, MN
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Struthers Parkinson`S Center
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Feinstein Institute For Medical Research, North Shore-Lij Health System
mi
from
Manhasset, NY
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Feinstein Institute For Medical Research, North Shore-Lij Health System
mi
from
Manhasset, NY
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Pennsylvania Hospital
mi
from
Philadelphia, PA
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
University of Vermont
mi
from
Burlington, VT
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated:  9/28/2015
Universitatsklinikum Giessen U. Marburg GmbH
mi
from
Standort Marburg,
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Status: Enrolling
Updated: 9/28/2015
Universitatsklinikum Giessen U. Marburg GmbH
mi
from
Standort Marburg,
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated:  9/30/2015
Pfizer Investigational Site
mi
from
Aventura, FL
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 9/30/2015
Pfizer Investigational Site
mi
from
Aventura, FL
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated:  9/30/2015
Pfizer Investigational Site
mi
from
Baco Raton, FL
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 9/30/2015
Pfizer Investigational Site
mi
from
Baco Raton, FL
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated:  9/30/2015
Pfizer Investigational Site
mi
from
South Miami, FL
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 9/30/2015
Pfizer Investigational Site
mi
from
South Miami, FL
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated:  9/30/2015
Pfizer Investigational Site
mi
from
Bingham Farms, MI
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 9/30/2015
Pfizer Investigational Site
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated:  9/30/2015
Pfizer Investigational Site
mi
from
Raleigh, NC
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 9/30/2015
Pfizer Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
Rush University Medical Center
mi
from
Chicago, IL
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
University of Chicago
mi
from
Chicago, IL
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
Columbia University Medical Center
mi
from
New York, NY
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
Cornell Univ Med Ctr
mi
from
New York, NY
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
Cornell Univ Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated:  10/2/2015
Oregon Health and Science University
mi
from
Portland, OR
Fox Investigation for New Discovery of Biomarkers
Fox Investigation for New Discovery of Biomarkers (BioFIND)
Status: Enrolling
Updated: 10/2/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/2/2015
California Clinical Trials
mi
from
Glendale, CA
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/2/2015
California Clinical Trials
mi
from
Glendale, CA
Click here to add this to my saved trials
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/2/2015
PARAXEL International
mi
from
Baltimore, MD
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/2/2015
PARAXEL International
mi
from
Baltimore, MD
Click here to add this to my saved trials
Electromyography Signals as Biomarkers for Parkinson's Disease
Electromyography Signals as Biomarkers for Parkinson's Disease
Status: Enrolling
Updated:  10/7/2015
Norconnect Inc.
mi
from
Ogdensburg, NY
Electromyography Signals as Biomarkers for Parkinson's Disease
Electromyography Signals as Biomarkers for Parkinson's Disease
Status: Enrolling
Updated: 10/7/2015
Norconnect Inc.
mi
from
Ogdensburg, NY
Click here to add this to my saved trials
Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
Randomized Controlled Clinical Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
Status: Enrolling
Updated:  10/8/2015
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
Randomized Controlled Clinical Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
Status: Enrolling
Updated: 10/8/2015
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated:  10/15/2015
Balance Disorders Clinic
mi
from
Tallahassee, FL
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated: 10/15/2015
Balance Disorders Clinic
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated:  10/15/2015
Fitness and Wellness Center
mi
from
Tallahassee, FL
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated: 10/15/2015
Fitness and Wellness Center
mi
from
Tallahassee, FL
Click here to add this to my saved trials